{"ModuleTitle": "Company Description", "CompanyName": "Agios Pharmaceuticals, Inc.", "Symbol": "AGIO", "Address": "88 SIDNEY STREET, CAMBRIDGE, Massachusetts, 02139, United States of America", "Phone": "617-649-8600", "Industry": "Major Pharmaceuticals", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "Item 1. Business\r\nWe are a biopharmaceutical company committed to the fundamental transformation\r\nof patients' lives through scientific leadership in the field of cellular\r\nmetabolism, with the goal of making transformative, first- or best-in-class\r\nmedicines. Our therapeutic areas of focus are cancer and rare genetic diseases,\r\nor RGDs, which are diseases that are directly caused by changes in genes or\r\nchromosomes, often passed from one generation to the next. Most RGDs are often\r\nassociated with severe or life-threatening features. The incidence of a single\r\nRGD can vary widely but is generally very infrequent, usually equal to or less\r\nthan one per 100,000 births. In both areas of cancer and RGDs, we are seeking to\r\nunlock the biology of cellular metabolism as a platform to create transformative\r\ntherapies.\r\nOur first commercial cancer product is IDHIFA\u00ae.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2018%2f02%2f14%2f0001439222-18-000004.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Andrew J. Hirsch", "title": "CFO & Head-Corporate Development"}, {"name": "Bruce Car", "title": "Chief Scientific Officer"}, {"name": "Christopher J. Bowden", "title": "Chief Medical Officer"}, {"name": "Jacqualyn A. Fouse", "title": "Chief Executive Officer & Director"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}